4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001062993-23-016714
Options or other derivatives
- Pres. Diagnostics & Genom acquired 59,625 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kelderman Kim Pres. Diagnostics & Genom | 2023-08-15 | Grant or award · Restricted Stock Units | +8,191 | 8,191 | D | ||
| Kelderman Kim Pres. Diagnostics & Genom | 2023-08-15 | Grant or award · Stock Options (Right to Buy) | +22,043 | 22,043 | D | ||
| Kelderman Kim Pres. Diagnostics & Genom | 2023-08-15 | Grant or award · Stock Options (Right to Buy) | +29,391 | 29,391 | D | ||
Loading xslF345X05/form4.xml…